Platelet Response to Clopidogrel Is Attenuated in Diabetic Patients Undergoing Coronary Stent Implantation

PRODUCT LITERATURE

Platelet Response to Clopidogrel Is Attenuated in Diabetic Patients Undergoing Coronary Stent Implantation

GEISLER, T - Personal Name;

Type 2 diabetes is accompanied by platelet function disorders leading to an accelerated process of atherosclerosis and increased risk for atherothrombotic complications (1–4). Previous data (5,6) suggest a worse outcome for diabetic patients after acute coronary
events. Recently, a high variability of response to clopidogrel measured by platelet function tests has been reported (7)
among patients with percutaneous coronary intervention (PCI), and hyporesponsiveness to clopidogrel has been considered to influence cardiac outcome in these patients (8–10).

Availability

Location name is not set Location name is not set

Vaclo-012

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Vaclo
Clopidogrel
Coronary Stent Implantation
Specific Detail Info: -
Statement of Responsibility: DIABETES CARE 2007;30(2): 372-374

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment